Key players in Benign Prostatic Hyperplasia Treatment
In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.
| # | Company | Website | Our reports |
|---|---|---|---|
| 1 |  Boston Scientific Corporation |
bostonscientific.com (opens in a new tab) | 957 reports |
| 2 | Teleflex Inc | — | 165 reports |
| 3 | Olympus Corporation | — | 495 reports |
| 4 | Procept BioRobotics | — | 33 reports |
| 5 | Astellas Pharma Inc. | — | 264 reports |
Also active in Benign Prostatic Hyperplasia Treatment
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
| Company | Where public records show them |
|---|---|
| Resurge Therapeutics Inc. |
|
| Addpharma Inc. |
|
| Urotronic Inc. |
|
| ProVerum Medical |
|
| Vivifi Medical |
|
| Butterfly Medical Ltd. |
|
| Andromeda Surgical |
|
| Zenflow, Inc. |
|
| ProArc Medical |
|
Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Top trial sponsors in Benign Prostatic Hyperplasia Treatment
Companies leading the most active studies found with this market's trial search, worldwide (key players included).
- Resurge Therapeutics Inc. 3 active trials on ClinicalTrials.gov (opens in a new tab)
- Addpharma Inc. 3 active trials on ClinicalTrials.gov (opens in a new tab)
- Urotronic Inc. 3 active trials on ClinicalTrials.gov (opens in a new tab)
- ProVerum Medical 3 active trials on ClinicalTrials.gov (opens in a new tab)
- Vivifi Medical 2 active trials on ClinicalTrials.gov (opens in a new tab)
- Olympus Corporation 2 active trials on ClinicalTrials.gov (opens in a new tab)
- Butterfly Medical Ltd. 2 active trials on ClinicalTrials.gov (opens in a new tab)
- Andromeda Surgical 2 active trials on ClinicalTrials.gov (opens in a new tab)
Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Benign Prostatic Hyperplasia Treatment reports by place
Australia
Brazil
Canada
China
Ecuador
Egypt
France
Germany
Hong Kong
India
Italy
Japan
Kenya
Malaysia
Mexico
New Zealand
PhilippinesGet the full Benign Prostatic Hyperplasia Treatment report
Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.
Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.